Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the detailed record of transactions filed by Brege Laura, Consejero. Director active across 3 companies, notably Pacira BioSciences, Inc.. Cumulatively, 19 disclosures have been logged. Split: 1 buy · 4 sells. Total volume traded: €625k. History available since 9 June 2021. The latest transaction was filed on 11 September 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Brege Laura
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Brege Laura is Administrateur at Pacira BioSciences, Inc., Acadia Pharmaceuticals INC and Mirum Pharmaceuticals, Inc. She has 19 filings in total, and across the 19 sampled filings the buy amounts are EUR 11674 and the sell amounts are EUR 613028, covering the period from 2021-06-11 to 2026-06-12. The most common transaction nature is Levée d'options.